Cargando…

RhoA enhances osteosarcoma resistance to MPPa-PDT via the Hippo/YAP signaling pathway

BACKGROUND: Osteosarcoma (OS) is the most prevalent primary bone malignancy affecting adolescents, yet the emergence of chemoradiotherapeutic resistance has limited efforts to cure affected patients to date. Pyropheophorbide-α methyl ester-mediated photodynamic therapy (MPPa-PDT) is a recently devel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhan, Fangbiao, He, Tao, Chen, Zhiyu, Zuo, Qiang, Wang, Yang, Li, Qiaochu, Zhong, Shenxi, Ou, Yunsheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8501741/ https://www.ncbi.nlm.nih.gov/pubmed/34627383 http://dx.doi.org/10.1186/s13578-021-00690-6

Ejemplares similares

SAR1A regulates the RhoA/YAP and autophagy signaling pathways to influence osteosarcoma invasion and metastasis
por: Zhan, Fangbiao, et al.
Publicado: (2022)

The mevalonate pathway promotes the metastasis of osteosarcoma by regulating YAP1 activity via RhoA
por: Du, Xing, et al.
Publicado: (2020)

Targeting GRP78 enhances the sensitivity of HOS osteosarcoma cells to pyropheophorbide-α methyl ester-mediated photodynamic therapy via the Wnt/β-catenin signaling pathway
por: Zuo, Qiang, et al.
Publicado: (2021)

Homologous targeting nanoparticles for enhanced PDT against osteosarcoma HOS cells and the related molecular mechanisms
por: Wang, Yang, et al.
Publicado: (2022)

Correction to: Homologous targeting nanoparticles for enhanced PDT against osteosarcoma HOS cells and the related molecular mechanisms
por: Wang, Yang, et al.
Publicado: (2022)

MPPa-PDT suppresses breast tumor migration/invasion by inhibiting Akt-NF-κB-dependent MMP-9 expression via ROS
por: Huang, Liyi, et al.
Publicado: (2019)

Hippo/YAP signaling pathway is involved in osteosarcoma chemoresistance
por: Wang, Dong-Yu, et al.
Publicado: (2016)

p190A inactivating mutations cause aberrant RhoA activation and promote malignant transformation via the Hippo-YAP pathway in endometrial cancer
por: Wen, Xiaoli, et al.
Publicado: (2020)

The Correlation between YAP and RhoA Expression in Prostate and Ovarian Tumor Stroma
por: Lee, Myung-Jin, et al.
Publicado: (2022)

Rho-GEF Trio regulates osteosarcoma progression and osteogenic differentiation through Rac1 and RhoA
por: Wang, Junyi, et al.
Publicado: (2021)

NPFFR2 Contributes to the Malignancy of Hepatocellular Carcinoma Development by Activating RhoA/YAP Signaling
por: Shin, Yuna, et al.
Publicado: (2022)

Antitumor effects and mechanisms of pyropheophorbide-α methyl ester-mediated photodynamic therapy on the human osteosarcoma cell line MG-63
por: Chen, Yanyang, et al.
Publicado: (2020)

YAP and the Hippo pathway in cholangiocarcinoma
por: Sugihara, Takaaki, et al.
Publicado: (2019)

RhoA deficiency disrupts podocyte cytoskeleton and induces podocyte apoptosis by inhibiting YAP/dendrin signal
por: Huang, Zongshun, et al.
Publicado: (2016)

A RhoA–YAP–c-Myc signaling axis promotes the development of polycystic kidney disease
por: Cai, Jing, et al.
Publicado: (2018)

Cytoskeletal alteration modulates cancer cell invasion through RhoA-YAP signaling in stromal fibroblasts
por: Kim, Do Kyeong, et al.
Publicado: (2019)

Resveratrol suppresses breast cancer cell invasion by inactivating a RhoA/YAP signaling axis
por: Kim, Yu Na, et al.
Publicado: (2017)

The Short-Chain Fatty Acid Receptor GPR43 Modulates YAP/TAZ via RhoA
por: Park, Bi-Oh, et al.
Publicado: (2021)

JTE-013 Alleviates Pulmonary Fibrosis by Affecting the RhoA/YAP Pathway and Mitochondrial Fusion/Fission
por: Zhou, Jiaxu, et al.
Publicado: (2023)

Histamine-induced biphasic activation of RhoA allows for persistent RhoA signaling
por: Zhang, Jason Z., et al.
Publicado: (2020)

RhoA improves cryopreservation of rooster sperm through the Rho/RhoA-associated kinase/cofilin pathway
por: Heng, Nuo, et al.
Publicado: (2022)

Establishment and characterization of human osteosarcoma cells resistant to pyropheophorbide-α methyl ester-mediated photodynamic therapy
por: Tao, Yong, et al.
Publicado: (2017)

YAP and MRTF-A, transcriptional co-activators of RhoA-mediated gene expression, are critical for glioblastoma tumorigenicity
por: Yu, Olivia M, et al.
Publicado: (2018)

Integrin β3 overexpression contributes to podocyte injury through inhibiting RhoA/YAP signaling pathway
por: Li, Zhuo, et al.
Publicado: (2021)

A YAP/TAZ–ARHGAP29–RhoA Signaling Axis Regulates Podocyte Protrusions and Integrin Adhesions
por: Rogg, Manuel, et al.
Publicado: (2023)

RhoA/Rho kinase in spinal cord injury
por: Wu, Xiangbing, et al.
Publicado: (2016)

Hippo-YAP/TAZ signaling in angiogenesis
por: Park, Jeong Ae, et al.
Publicado: (2018)

Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms
por: Dobrokhotov, Oleg, et al.
Publicado: (2018)

Prognostic value of the Hippo pathway transcriptional coactivators YAP/TAZ and β1-integrin in conventional osteosarcoma
por: Bouvier, Corinne, et al.
Publicado: (2016)

Open Conformation of the Escherichia coli Periplasmic Murein Tripeptide Binding Protein, MppA, at High Resolution
por: Bhatt, Forum, et al.
Publicado: (2018)

RhoA/ROCK-YAP/TAZ Axis Regulates the Fibrotic Activity in Dexamethasone-Treated Human Trabecular Meshwork Cells
por: Liu, Zhicheng, et al.
Publicado: (2021)

RhoA‐ROCK competes with YAP to regulate amoeboid breast cancer cell migration in response to lymphatic‐like flow
por: Mohammadalipour, Amina, et al.
Publicado: (2022)

PLAGL2 promotes bladder cancer progression via RACGAP1/RhoA GTPase/YAP1 signaling
por: Chen, Hualin, et al.
Publicado: (2023)

Theaflavin-3,3′-Digallate Plays a ROS-Mediated Dual Role in Ferroptosis and Apoptosis via the MAPK Pathway in Human Osteosarcoma Cell Lines and Xenografts
por: He, Tao, et al.
Publicado: (2022)

RhoA controls furrow formation
por: Tuma, Rabiya S.
Publicado: (2005)

RhoA brings up the rear
por: Dove, Alan W.
Publicado: (2001)

Complementary receptors control RhoA
por: Robinson, Richard
Publicado: (2008)

RhoA Regulation of Cardiomyocyte Differentiation
por: Kaarbø, Mari, et al.
Publicado: (2013)

RhoA in aneurysmal subarachnoid hemorrhage
por: Ureña, Juan, et al.
Publicado: (2019)

RhoA Signaling in Neurodegenerative Diseases
por: Schmidt, Sissel Ida, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0nctaue0q751q05e9fe1bgpe16